Wound Cleanser Products Market Size, Share and Global Trend By Type (Sprays, Solutions, Wipes, Foams), By Wound Type (Surgical Wounds, Chronic Wounds, Acute Wounds), By End-User (Clinics, Hospitals, Ambulatory Surgery Centers, Home Care Settings) and Regional Forecast, 2024-2032

In February 2016, Italy based company Angelini ACRAF S.p.A launched TEHCLO, a wound cleanser technology which developed to treat diabetic and surgical wounds. Wound cleanser products are utilized to remove wound contaminants, foreign particles, and to clean wound surface. Also, wound cleanser products help to optimize the wound healing process and reduce the risk of wound infection.

According to the World Health Organization (WHO), each year, an estimated 180,000 deaths are caused due to severe burns in emerging countries. Certain benefits such as faster recovery, reduction in chemical irritation, reduction in mechanical trauma, and development of a favourable environment for rapid wound recovery are offered by wound cleanser products.

Rising incidence of surgical wounds and surgical site infections, growing prevalence of chronic diseases and frequently reported cases of burns are driving the growth of the global wound cleanser products market. Additionally, the ageing population, prolonged life expectancy due to improved wound treatment, frequently reported cases of wound infections are expected to drive the growth of the global wound cleanser products market during the forecast period.

However, lack of nurse education, lack of awareness about the consequences of prolonged wounds and unavailability of wound care instruments in emerging countries considered to deter the growth of the global wound cleanser products market.

Key Players Covered

Some of the major companies that are present in the global wound cleanser products market are 3M, Angelini Acraf S.p.A., Integra LifeSciences, DermaRite Industries, LLC., Johnson & Johnson Services, Inc., Hollister Incorporated, Smith & Nephew Healthcare Pvt. Ltd., Coloplast Ltd., DeRoyal Industries, Inc., Mölnlycke Health Care AB, Cremer, BSN Medical, Medline Industries, Inc., B. Braun Melsungen AG, NovaBay Pharmaceuticals, Inc., Winner Medical Group Inc. and others.

SEGMENTATION

Among the segmentation, chronic wound type in wound type segment is projected to hold a significant share of the market owing to the increasing prevalence of chronic wounds.

Key Insights

• The regulatory scenario for key countries


• New product introduction


• Recent developments in wound cleanser products


• Prevalence of surgical wounds for key countries


• Recent industry developments such as partnerships, mergers, and acquisitions

Regional Analysis

On the basis of region, the global wound cleanser products market is segmented as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global wound cleanser products market owing to the rising prevalence of surgical wounds as well as chronic wounds and fatal injuries. Combined with these factors growing number of surgeries, rising healthcare expenditure, and growth in disposable income had led to growth in global wound cleanser products market in this particular region. The Asia Pacific and Middle East & Africa hold huge potential for global wound cleanser products market owing to growth in demand for improved measures against wound infections, growth in trauma, and rising emphasis on better patient care. Moreover, a large patient pool and rising per capita expenditure along with rapidly growing healthcare infrastructure offers a huge opportunity for growth of the global wound cleanser products market in emerging nations during the forecast period.

Key Industry Developments

• In June 2019, Sanara MedTech Inc. announced the official launch of BIAKOS Antimicrobial Skin & Wound Cleanser. The newly developed spray which disrupts extracellular polymeric substances to eradicate biofilm.
• In October 2018, Cigalah Medpharm launched Nexodyn AOS, an advanced wound cleanser technology in UAE and Saudi Arabia.
• In July 2018, Oculus agreed upon strategic partnership with Genetix Biotech to develop and launch wound care products in the global market.